Literature DB >> 10448532

Transgenic models of growth hormone action.

J J Kopchick1, L L Bellush, K T Coschigano.   

Abstract

A growth-promoting principle of the pituitary gland was discovered in 1921, and bovine growth hormone (GH) was isolated in 1944. Since then, the structure of GH as it relates to its biological activities has been an exciting research topic. Equally fascinating is the relationship between GH structure and its metabolic activities. In attempts to define some of these activities, several investigators have used GH transgenic mice as models. In this review we summarize what is known about the molecular mechanisms of GH action. We then describe some of the GH transgenic models and point out potential targets for nutrition research.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10448532     DOI: 10.1146/annurev.nutr.19.1.437

Source DB:  PubMed          Journal:  Annu Rev Nutr        ISSN: 0199-9885            Impact factor:   11.848


  38 in total

Review 1.  The role of circulating IGF-I: lessons from human and animal models.

Authors:  Shoshana Yakar; Yiping Wu; Jennifer Setser; Clifford J Rosen
Journal:  Endocrine       Date:  2002-12       Impact factor: 3.633

2.  Growth hormone abolishes beneficial effects of calorie restriction in long-lived Ames dwarf mice.

Authors:  Adam Gesing; Khalid A Al-Regaiey; Andrzej Bartke; Michal M Masternak
Journal:  Exp Gerontol       Date:  2014-08-21       Impact factor: 4.032

Review 3.  Altered structure and function of adipose tissue in long-lived mice with growth hormone-related mutations.

Authors:  Justin Darcy; Samuel McFadden; Andrzej Bartke
Journal:  Adipocyte       Date:  2017-03-21       Impact factor: 4.534

4.  Prolonged exposure to GH impairs insulin signaling in the heart.

Authors:  J G Miquet; J F Giani; C S Martinez; M C Muñoz; L González; A I Sotelo; R K Boparai; M M Masternak; A Bartke; F P Dominici; D Turyn
Journal:  J Mol Endocrinol       Date:  2011-08-30       Impact factor: 5.098

5.  Downregulation of the ACE2/Ang-(1-7)/Mas axis in transgenic mice overexpressing GH.

Authors:  Marina C Muñoz; Valeria Burghi; Johanna G Miquet; Jorge F Giani; Ricardo D Banegas; Jorge E Toblli; Yimin Fang; Feiya Wang; Andrzej Bartke; Fernando P Dominici
Journal:  J Endocrinol       Date:  2014-04-22       Impact factor: 4.286

6.  Increased fibrosis: A novel means by which GH influences white adipose tissue function.

Authors:  Lara A Householder; Ross Comisford; Silvana Duran-Ortiz; Kevin Lee; Katie Troike; Cody Wilson; Adam Jara; Mitchell Harberson; Edward O List; John J Kopchick; Darlene E Berryman
Journal:  Growth Horm IGF Res       Date:  2017-12-20       Impact factor: 2.372

7.  Prkar1a haploinsufficiency ameliorates the growth hormone excess phenotype in Aip-deficient mice.

Authors:  Marie Helene Schernthaner-Reiter; Giampaolo Trivellin; Thomas Roetzer; Johannes A Hainfellner; Matthew F Starost; Constantine A Stratakis
Journal:  Hum Mol Genet       Date:  2020-10-10       Impact factor: 6.150

8.  Hepatocellular alterations and dysregulation of oncogenic pathways in the liver of transgenic mice overexpressing growth hormone.

Authors:  Johanna G Miquet; Thomas Freund; Carolina S Martinez; Lorena González; María E Díaz; Giannina P Micucci; Elsa Zotta; Ravneet K Boparai; Andrzej Bartke; Daniel Turyn; Ana I Sotelo
Journal:  Cell Cycle       Date:  2013-02-21       Impact factor: 4.534

9.  Excessive growth hormone expression in male GH transgenic mice adversely alters bone architecture and mechanical strength.

Authors:  S V Lim; M Marenzana; M Hopkinson; E O List; J J Kopchick; M Pereira; B Javaheri; J P Roux; P Chavassieux; M Korbonits; C Chenu
Journal:  Endocrinology       Date:  2015-02-03       Impact factor: 4.736

10.  Altered somatotroph feedback regulation improves metabolic efficiency and limits adipose deposition in male mice.

Authors:  Christopher J Romero; Andrew Wolfe; Yi Ying Law; ChenChen Z Costelloe; Ryan Miller; Fredric Wondisford; Sally Radovick
Journal:  Metabolism       Date:  2015-12-08       Impact factor: 8.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.